Trump shares Aliyev’s Shusha Forum speech on Truth Social again
Donald Trump has once again shared a video clip of Azerbaijani President Ilham Aliyev’s remarks from the Shusha Global Media Forum on his Truth Soci...
On the sun-soaked southern tip of China, a new kind of medical tourism is quietly unfolding. It’s not about cosmetic surgery or wellness spas but about survival.
Every month, hundreds of desperate cancer patients from across China and increasingly, from Southeast Asia and the Middle East, arrive in Hainan - lured by a unique promise of access to cutting-edge, experimental cancer drugs.
The Boao Lecheng Pilot Zone, a specially designated medical tourism hub in Hainan, is at the heart of this surge. Under a rare regulatory framework approved by Beijing, hospitals and biotech partners here are allowed to import and administer unapproved, investigational drugs - without waiting for the usually lengthy national regulatory approval process.
“We came here because we were out of options,” said Liu Mei, a 47-year-old schoolteacher from Sichuan, whose husband is undergoing treatment for late-stage liver cancer. “This is the only place we could try something new before it’s too late.”
Launched in 2019, the Boao Lecheng zone was envisioned as a sandbox for medical innovation. Today, it houses more than 20 hospitals and clinics, many in partnership with pharmaceutical giants and startups alike. Drugs that have passed safety and efficacy trials overseas - particularly in the US, Japan, and Europe - can be fast-tracked for use here.
One such drug is Tarlatamab, a novel lung cancer therapy developed by Amgen that’s still awaiting full approval in China but is already being used in Boao. For many patients, it’s a last-ditch shot at extending life.
“This model flips the script,” said Dr. Wang Jinxin, oncologist at the Boao Evergrande International Hospital. “We are giving people access to hope — not in five years, but now.”
Yet, the zone’s rapid growth has sparked debate. Critics argue that fast-tracking unapproved drugs risks undermining clinical trial standards and may exploit vulnerable patients.
“This is not a controlled clinical trial , this is compassionate use under a loophole,” said Dr. Li Haoran, a Beijing-based bioethicist.
Patients must sign extensive waivers acknowledging the experimental nature of the drugs. Some pay out of pocket, with costs reaching tens of thousands of yuan per treatment cycle and insurance rarely covers it, yet, many are willing to take that gamble.
“I’m not waiting for paperwork in Beijing while cancer spreads,” said Xu Jinrong, a former logistics worker with advanced gastric cancer. “If I have one chance, I’ll take it.”
The Boao model is also closely being monitored by global pharmaceutical companies. Hainan offers real-world testing environments for their products in a country with a massive patient base - without full regulatory delays.
Some observers believe Hainan’s success could pave the way for regulatory overhauls across China and beyond.
“What’s happening in Hainan is China’s play to become a global hub for medical innovation,” said Daniel Zhang, an analyst at SinoHealth Research. “If it works here, they’ll scale it.”
As Beijing expands the Boao zone and courts more biotech investment, the line between innovation and experimentation may grow thinner. For now, Hainan stands as a unique and controversial experiment in fast-access medicine.
And for those who arrive with hope packed into carry-ons and plastic medical folders, the island offers them the second chance they often can’t find elsewhere.
The world’s biggest dance music festival faces an unexpected setback as a fire destroys its main stage, prompting a last-minute response from organisers determined to keep the party alive in Boom, Belgium.
According to the German Research Centre for Geosciences (GFZ), a magnitude 5.7 earthquake struck the Oaxaca region of Mexico on Saturday.
China and the Association of Southeast Asian Nations will send an upgraded ‘version 3.0’ free-trade agreement to their heads of government for approval in October, Chinese Foreign Minister Wang Yi said on Saturday after regional talks in Kuala Lumpur.
A resumption of Iraq’s Kurdish oil exports is not expected in the near term, sources familiar with the matter said on Friday, despite an announcement by Iraq’s federal government a day earlier stating that shipments would resume immediately.
Chinese automaker Chery has denied an industry-ministry audit that disqualified more than $53 million in state incentives for thousands of its electric and hybrid vehicles, insisting it followed official guidance and committed no fraud.
Tech giant Google has announced a $1 billion investment to support Artificial Intelligence (AI) education and research at universities across the United States.
What shapes human nature? Why do some people act with compassion while others turn cruel? For centuries, thinkers — from philosophers and playwrights to theologians and psychologists — have grappled with these timeless questions, searching for what lies at the heart of good and evil.
A new skin cancer drug has been developed using a genetically engineered virus that targets and replicates only cancer cells. That's according to public broadcaster NHK who said that researchers in Japan found that 77.8% of those tested, improved.
Adults are inhaling around 68,000 microplastic particles each day, researchers warn, over 100 times previous estimates.
Americans will soon be able to access and share their medical records through a new “digital health tech ecosystem”, unveiled by U.S. President Donald Trump in partnership with more than 60 major technology companies.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment